Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia

NCT03571087 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

374

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia

Interventions

DRUG: HL140 5/10
DRUG: HL140 10/10
DRUG: HL140 20/10
DRUG: Rosuvastatin 5mg → HL140 5/10
DRUG: Rosuvastatin 10mg → HL140 10/10
DRUG: Rosuvastatin 20mg → HL140 20/10

Sponsor

Hanlim Pharm. Co., Ltd.